Paper · 7002129
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.
Wilson WR and 2 others. Arch Otolaryngol, 1980. Cited by 699 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Papers, record 7002129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7002129
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucocorticoids | Major topic |
| Hearing Loss, Sensorineural | Major topic |
| Adult | |
| Age Factors | |
| Clinical Trials as Topic | |
| Dexamethasone | |
| Double-Blind Method | |
| Humans | |
| Methylprednisolone | |
| Placebos |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NS 15629 | NINDS NIH HHS | United States | R01NS015629 | PubMed and NIH |
Source NIH RePORTER
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT07134075 | Intracochlear Injection of Glucocorticoid | Background | ClinicalTrials.gov | |
| NCT07540728 | Trans-round Window Membrane Intracochlear Steroid | Background | ClinicalTrials.gov | |
| NCT07814677 | Efficacy and Safety of Intracochlear Injection of Glucocorticoid Through the Round Window Membrane in Patients With Profound or Complete Sudden Sensorineural Hearing Loss | Background | ClinicalTrials.gov |
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by217
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 699 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,982,521 | Study protocol of the SuDHO study: hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomised controlled trial. | BMJ Open | 2026 | https://conductscience.org/library/papers/42982521 | PubMed |
| 42,746,638 | Sensorineural Hearing Loss and Phosphodiesterase-5 Inhibitors: A Systematic Review. | Int Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42746638 | PubMed |
| 42,543,415 | Differentiating hidden meniere's disease from typical sudden sensorineural hearing loss: clinical significance of acute low-tone hearing loss. | Eur Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42543415 | PubMed |
| 42,383,431 | Optimal Timing of Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Mini-Review. | Medeni Med J | 2026 | https://conductscience.org/library/papers/42383431 | PubMed |
| 42,230,800 | Semicircular canal dysfunction in profound sudden sensorineural hearing loss and its prognostic value: implications for the proper indication of hyperbaric oxygen therapy. | Sci Rep | 2026 | https://conductscience.org/library/papers/42230800 | PubMed |
| 41,948,607 | Seasonal effects on incidence and outcomes in idiopathic sudden sensorineural hearing loss. | Front Neurol | 2026 | https://conductscience.org/library/papers/41948607 | PubMed |
| 41,567,673 | Relationship between different blood routine parameters and different types of sudden deafness and prognosis. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41567673 | PubMed |
| 41,327,826 | Harnessing Machine Learning for Personalized Care of Patients With Idiopathic Sudden Sensorineural Hearing Loss: A Multicenter Cohort Study. | Clin Exp Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/41327826 | PubMed |
| 41,312,345 | Several proteins derived from serum exosomes are potential biomarkers for diagnosis and progression of sudden sensorineural hearing loss. | Front Neurol | 2025 | https://conductscience.org/library/papers/41312345 | PubMed |
| 40,994,247 | A novel audiogram model for predicting the prognosis of sudden sensorineural hearing loss. | J Chin Med Assoc | 2025 | https://conductscience.org/library/papers/40994247 | PubMed |
1 to 10 of 217
See all 217 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7002129
GET https://conductscience.org/api/papers/v1/7002129/cited_by?page=2